A novel macrolide compound from Streptomyces bingchenggensis: Fermentation, isolation, structure elucidation and biological properties

Journal of Antibiotics

Volumn 62, Issue 4, 2009, Pages 229-231

  Xiang, Wen Sheng ^a   Wang, Ji Dong ^a,b   Wang, Xiang Jing ^a   Zhang, Ji ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b Zhejiang Hisun Pharmaceutical Co Ltd   (China)

Author keywords

Cytotoxic activity; Novel macrolide compound; ST906 (1); Streptomyces bingchenggensis

Indexed keywords

MACROLIDE; MILBEMYCIN DERIVATIVE; ST 906; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG PURIFICATION; FERMENTATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROPHOTOMETER; STREPTOMYCES; STREPTOMYCES BINGCHENGGENSIS; STRUCTURE ACTIVITY RELATION;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FERMENTATION; HUMANS; MACROLIDES; MAGNETIC RESONANCE SPECTROSCOPY; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STREPTOMYCES;

STREPTOMYCES;

EID: 67249114338     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2009.14     Document Type: Article

References (9)

1. Lam, K. S. New aspects of natural products in drug discovery. Trends Microbiol. 15, 279-289 (2007).
2. Harvey, A. L. Natural products as a screening resource. Curr. Opin. Chem. Biol. 11, 480-484 (2007).
3. Gullo, V. P., McAlpine, J., Lam, K. S., Baker, D. & Petersen, F. Drug discovery from natural products. J. Ind. Microbiol. Biotechnol. 33, 523-531 (2006).
4. Xiang, W. S., Wang, J. D, Wang, X. J. & Zhang, J. Two new-class milbemycins from Streptomyces bingchenggensis fermentation, isolation, structure elucidation and biological properties. J. Antibiot. 60, 351-356 (2007).
5. Xiang, W. S., Wang, J. D., Wang, X. J., Zhang, J. & Wang, Z. Further new milbemycin antibiotics from Streptomyces bingchenggensis. J. Antibiot. 60, 608-613 (2007).
6. Xiang, W. S., Wang, J. D., Fan, H. M., Wang, X. J. & Zhang, J. New seco-milbemycins from Streptomyces bingchenggensis: fermentation, isolation and structure elucidation. J. Antibiot. 60, 27-32 (2008).
7. Wang, J. D. et al. HS071, a new furan-type cytotoxic metabolite from Streptomyces sp. HS-HY-071. J. Antibiot. 61, 623-626 (2008).
8. Nonaka, K. et al. New milbemycins from Streptomyces hygroscopicus subsp. aureolacrimosus: fermentation, isolation and structure elucidation. J. Antibiot. 53, 694-704 (2000).
9. Bovden, W. I., Anthony, P. J., Thomas, C. G., Jennings, T. M. & Michael, G. Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents. European Patent. 170006, 2 May (1986).